Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011426 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Thamer Alghamdi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Hepatobiliary Surgery, Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia. Hauptthemen laut MEDLINE: Schistosomiasis mansoni, Ziziphus, Schistosomiasis, Anthelmintics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, al Baha University.
Abstract (Originalsprache)
Background
Schistosomiasis is one of the most prevalent helminthic infections worldwide. Praziquantel (PZQ) resistance poses a possible danger to the disease’s ability to be controlled. Little is known about the role of Ziziphus spina-christi leaf extract (ZLE) in the treatment of hepatic schistosomiasis. However, no study has explored ZLE’s anti-angiogenic and anti-proliferative activity as a possible mechanism for reducing hepatic injury in this context. Therefore, this study aimed to evaluate the therapeutic potential of ZLE as an anti-angiogenic, and anti-proliferative agent in hamsters infected with S . mansoni .
Methods
Fifty hamsters were used and divided into 5 groups (10 hamsters each); noninfected untreated (controls), noninfected treated with ZLE, infected untreated, infected treated with PZQ- and infected treated with ZLE. Anti-angiogenic and anti-fibrotic effects of the drugs were assessed pathologically through the immunohistochemical expression of VEGF, Ki-67, and TGF β1 in liver sections. Some oxidative stress parameters were measured in hepatic homogenates (NO, GSH, GST, and SOD), and serum liver enzymes were also assessed.
Results
A significant decrease in worm burden, granuloma size, granuloma area, and numbers in the ZLE- and PZQ-treated groups compared to the infected untreated group, and the decrease in granulomas number and tissue egg load was significantly lower in PZQ treated group compared to ZLE treated group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Hepatobiliary Surgery, Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia.
- Department of Medical Parasitology, Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia.
- Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- Department of Medical Biochemistry, Faculty of Medicine, Al-Baha University, Al-Baha Saudi Arabia.
- Genetic Institute, Sadat City University, Sadat City, Egypt.
ORCID-Profile: Doaa A Salem
Förderung
- Deanship of Scientific Research, al Baha University
Zitieren
APA
Alghamdi, T., Salem, D. A., & El-Refaei, M. F. (2023). Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011426
Vancouver
Alghamdi T, Salem DA, El-Refaei MF. Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011426
BibTeX
@article{Alghamdi2023,
author = {Alghamdi, Thamer and Salem, Doaa A and El-Refaei, Mohamed F},
title = {Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011426}
}
EUVIMED